CD274 and hepatocellular carcinoma: Interestingly, targeting the CAF-M-MDSC crosstalk using p38 MAPK inhibitor significantly enhanced the efficacy of anti-PD-L1 therapy and led to tumor eradication, ultimately prolonging survival in the fibrotic-HCC mouse model [111].